AP NEWS
Press release content from Wired Release. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Wired Release
Press release content from Wired Release. The AP news staff was not involved in its creation.

Global Enzyme-Linked Immunosorbent Assay Market Is Driven By Increasing Prevalence Of Infectious Diseases

November 7, 2019 GMT

Pune, Maharashtra, November 07, 2019 (Wired Release) Prudour Pvt. Ltd. – Enzyme-linked immunosorbent assay is a biochemical technique used to detect antigens or antibodies in a sample. The ELISA is a diagnostic tool and is used in plant pathology, medicine, and food industry. It is a simple and quick procedure to identify antibodies, antigens, hormones, proteins, and peptides in biological samples. Antigens are those substances which stimulate the immune system in order to produce antibodies. The antibodies, also known as immunoglobulins are proteins that fight against foreign substances known as antigens.

Increasing prevalence of infectious diseases such as HIV, cancer, and others that are caused by viral, bacterial, mycotic, and parasitic organisms is a factor augmenting demand for enzyme-linked immunosorbent assay owing to its high sensitivity. ELISA is used to diagnose non-infectious diseases such as drugs, hormones, serum components, auto-immune diseases, and oncofetal proteins. Increasing RnD investments by the government in the healthcare sector in developing countries, and growing population, coupled with high disposable income are factors proliferating the demand for enzyme-linked immunosorbent assay. The worldwide market for enzyme-linked immunosorbent assay is expected to register significant CAGR of around 5.5 percent over the next ten years and was valued at 1,594.9 Mn in 2018.

Looking for Customized Insights to raise your business for the future, ask for a sample report at https://market.us/report/enzyme-linked-immunosorbent-assay-elisa-market/request-sample/

Availability of alternate immunoassays test and lack of affordability and accessibility of diagnostic tests in emerging countries are factors challenging the growth of the global market. Development of automated platforms to run ELISA and launch of innovative products owing to improve performance, flexibility, sensitivity, productivity, and cost-effective technology are factors creating new opportunities for players operating in the global market. Enzyme-linked immunosorbent assay is of two types i.e., ELISA sets and ELISA kits. ELISA kits are used to detect molecules or performing ligand-binding assays whereas the ELISA sets are used to develop enzyme-linked immunosorbent assays (ELISA) for natural or recombinant cells in serum, plasma, and cell culture supernatants. The reagents used in ELISA sets are stored at proper storage conditions but need to be brought at room temperature before use.

Enzyme-linked immunosorbent assay is used in various applications such as ELISA in HIV, ELISA in West Nile Virus, detecting antigens or antibodies and biodefense. It is used in the diagnosis of HIV infection, pregnancy tests, and measurement of soluble receptors or cytokines in serum or cell supernatant.

Any Questions? Fill Free To Inquire Here. Well Put You On The Right Path: https://market.us/report/enzyme-linked-immunosorbent-assay-elisa-market/

The market is segmented on the basis of geography such as North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Increasing investments in RnD for immunology and medicine, increasing pharmaceutical and biotechnology industries, and the presence of major players in countries are factors augmenting demand for enzyme-linked immunosorbent assay in the North America region. Growing pharmaceutical industry, increasing geriatric population, coupled with high spending capacity has a positive impact on the enzyme-linked immunosorbent assay market in Europe. Increasing investments by government and development of the healthcare sector especially for clinical diagnosis, and growing population, coupled with high disposable income in the Asia Pacific region are factors driving demand for enzyme-linked immunosorbent assay.

Some of the prominent players operating in the target market include RnD Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, ZEUS Scientific, Bio-Rad Laboratories, ALPCO, Enzo Life Sciences, BioMerieux, EMD Millipore, BioLegend, LOEWE Biochemica and Shenzhen YHLO Biotech.

Source:  https://media.market.us/global-enzyme-linked-immunosorbent-assay-market-is-driven-by-increasing-prevalence-of-infectious-diseases-across-the-globe/3596/